2022
DOI: 10.2478/rjr-2022-0003
|View full text |Cite
|
Sign up to set email alerts
|

Kikuchi-Fujimoto disease and systemic lupus erythematosus – an enigmatic association for clinicians and pathologists: Case report and short literature review

Abstract: Kikuchi-Fujimoto disease or histiocytic necrotizing lymphadenitis is a benign condition of the lymphatic tissue whose cause has not been fully elucidated. Although it has been thought that various viral infections are involved in the onset of the disease, its immunological characteristics expressed by the proliferation of cytotoxic CD8-positive T lymphocytes and histiocytic phagocytosis place it at the border of autoimmunity. Sharing immunological mechanisms, clinical manifestations, and epidemiological data (… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 20 publications
0
1
0
Order By: Relevance
“…In a review of 55 patients with KFD in the context of definite connective tissue disorder fifty were associated with SLE; 22 (40%) patients had simultaneous onset, 19 (35%) patients predated the onset, and 14 (25%) patients developed KFD after the onset of SLE[ 3 ]. KFD may also complicate preexisting SLE as described by Tarabichi et al [ 161 ] requiring intensive therapeutic intervention. Their patient of SLE, a 20-year-old girl, had been doing well with hydroxychloroquine (HCQS 200 mg/d)/analgesics.…”
Section: Kfd and Systemic Lupus Erythematosusmentioning
confidence: 99%
“…In a review of 55 patients with KFD in the context of definite connective tissue disorder fifty were associated with SLE; 22 (40%) patients had simultaneous onset, 19 (35%) patients predated the onset, and 14 (25%) patients developed KFD after the onset of SLE[ 3 ]. KFD may also complicate preexisting SLE as described by Tarabichi et al [ 161 ] requiring intensive therapeutic intervention. Their patient of SLE, a 20-year-old girl, had been doing well with hydroxychloroquine (HCQS 200 mg/d)/analgesics.…”
Section: Kfd and Systemic Lupus Erythematosusmentioning
confidence: 99%